Meralgia Paresthetica Market Research Report - Forecast till 2027

Meralgia Paresthetica Market Research Report: By Diagnosis (Imaging Techniques, Electromyography, Nerve Conduction Study, Nerve Blockade), Treatment (Medication, Surgery), End User (Hospitals & Clinics, Research Laboratories) - Forecast till 2027

ID: MRFR/MED/3870-HCR | | Region: Global | 105 pages

Meralgia Paresthetica Market Scenario


Meralgia paresthetica is a condition characterized by tingling, numbness and burning pain in outer thigh. The major cause of meralgia paresthetica is compression of the nerve that supplies sensation to the skin surface of the thigh. The meralgia paresthetica market growth is majorly attributed to the increasing prevalence of obesity, rising funding, and healthcare insurance coverage. Moreover, common causes of this compression includes any condition that increases pressure on the groin such as tight clothing i.e. belts, corsets and tight pants, obesity or weight gain, wearing a heavy tool belt, pregnancy, scar tissue near the inguinal ligament due to injury or any previous surgery. Furthermore, nerve injury, which due to diabetes or seat belt injury after an accident (by motor vehicle), can also cause meralgia paresthetica.


As per the National Diabetes Statistics Report suggested by the Centers for Disease Control and Prevention, it is found that 9.4% of the U.S. population i.e. 30.3 million people had diabetes in 2015. The rising prevalence of diabetes in low and middle-income countries appears to be fuelled by nutrition transition, rapid urbanization, and increasingly sedentary lifestyles, suggested by a study published in the journal Pharmacoeconomics in 2015. Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies. According to the World Health Organization estimates, head injuries are responsible for 4.5%-11% of all injuries in the world including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


On the other hand, availability of expensive treatment may hamper the meralgia paresthetica market growth during the forecast period.


The Meralgia Paresthetica Market is expected to grow at a CAGR of ~7.9 % during the forecast period 2017-2023.


Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Figure: Global Meralgia Paresthetica Market, By Region Market Share, 2016 (%) Meralgia Paresthetica Market

Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The Meralgia Paresthetica Market is segmented on the basis of types, by treatment, and by end user.


On the basis of diagnosis, meralgia paresthetica market is segmented into imaging techniques, electromyography, nerve conduction study, nerve blockade. Imaging techniques are further segmented as X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, and others.


Based on the treatment, meralgia paresthetica market is segmented into medication, surgery, and others. Medication is further segmented into corticosteroid injections, tricyclic antidepressants, and anti-seizure. Anti-seizure is further segmented into gabapentin (gralise, neurontin), phenytoin (Dilantin) or pregabalin (lyrica) and others.


On the basis of end user, meralgia paresthetica market is segmented into hospitals & clinics, research laboratories, and others.


Key Players


Some of key the players in the meralgia paresthetica market are LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.) and others.


Research Methodology
Meralgia Paresthetica Market 2018
Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The Americas dominate the meralgia paresthetica market owing to well-developed technology, increasing patient with obesity, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the meralgia paresthetica market owing to the government support for research & development and availability of funds for research. Moreover, this is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.    


Asia Pacific is the fastest growing meralgia paresthetica market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods for chronic diseases in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of meralgia paresthetica in the region.   


On the other hand, in the Middle East and Africa, obesity and diabetes have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.9% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Types, Treatment, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.) and others
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of obesity
  • Rising funding
  • Healthcare insurance coverage


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    meralgia paresthetica market is projected to grow at a 7.9% CAGR between 2017-2023.

    The Americas is expected to dominate the meralgia paresthetica market.

    Rising prevalence of obesity and globalization in healthcare are the key factors adding to the meralgia paresthetica market growth.

    The availability of cost-effective treatment may limit the meralgia paresthetica market growth.

    Key players profiled in the meralgia paresthetica market include Inspire Medical Systems, Inc. (U.S.), ImThera Medical (U.S.), NeuroMetrix, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), ElectroCore Medical LLC (U.S.), EnteroMedics Inc. (U.S.), and LivaNova PLC (U.K.).

    Table Of Content

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope Of The Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power Of Suppliers

    5.1.2 Bargaining Power Of Buyers

    5.1.3 Threat Of New Entrants

    5.1.4 Threat Of Substitutes

    5.1.5 Intensity Of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Meralgia Paresthetica Market, By Diagnosis

    6.1 Introduction

    6.2 Imaging Techniques

    6.2.1 Market Estimates & Forecast, 2020 – 2027

    6.3 Electromyography

    6.3.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 7. Global Meralgia Paresthetica Market, By Treatment

    7.1 Introduction

    7.2 Medication

    7.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3 Surgery

    7.3.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 8. Global Meralgia Paresthetica Market, By End User

    8.1 Introduction

    8.2 Hospitals & Clinics

    8.2.1 Market Estimates & Forecast, 2020 – 2027

    8.3 Research Laboratories

    8.3.1 Market Estimates & Forecast, 2020 – 2027

    8.4 Others

    Chapter 9. Global Meralgia Paresthetica Market, By Region

    9.1 Introduction

    9.2 America

    9.2.1 North America

    9.2.1.1 US

    9.2.1.1 Canada

    9.2.2 South America

    9.3 Europe

    9.3.1 Western Europe

    9.3.1.1 Germany

    9.3.1.2 France

    9.3.1.3 Italy

    9.3.1.4 Spain

    9.3.1.5 UK

    9.3.1.6 Rest Of Western Europe

    9.3.2 Eastern Europe

    9.4 Asia Pacific

    9.4.1 Japan

    9.4.2 China

    9.4.3 India

    9.4.4 Australia

    9.4.5 Republic Of Korea

    9.4.6 Rest Of Asia Pacific

    9.5 The Middle East & Africa

    9.5.1 United Arab Emirates

    9.5.2 Saudi Arabia

    9.5.3 Oman

    9.5.4 Kuwait

    9.5.5 Qatar

    9.5.6 Rest Of The Middle East & Africa

    Chapter 10 Company Landscape

    10.1 Introduction

    10.2 Market Share Analysis

    10.3 Key Development & Strategies

    10.3.1 Key Developments

    Chapter 11 Company Profiles

    11.1 Boston Scientific Corporation

    11.1.1 Company Overview

    11.1.2 Product Overview

    11.1.3 Financials

    11.1.4 SWOT Analysis

    11.2 ElectroCore Medical LLC

    11.2.1 Company Overview

    11.2.2 Product Overview

    11.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 EnteroMedics Inc

    11.3.1 Company Overview

    11.3.2 Product Overview

    11.3.3 Financial Overview

    11.3.4 Key Development

    11.3.5 SWOT Analysis

    11.4 LivaNova PLC

    11.4.1 Company Overview

    11.4.2 Product /Business Segment Overview

    11.4.3 Financial Overview

    11.4.4 Key Development

    11.4.5 SWOT Analysis

    11.5 Cyberonics, Inc.

    11.5.1 Company Overview

    11.5.2 Product Overview

    11.5.3 Financial Overview

    11.5.4 Key Developments

    11.6 NeuroMetrix, Inc.

    11.6.1 Company Overview

    11.6.2 Product Overview

    11.6.3 Financial Overview

    11.6.4 Key Developments

    11.7 Inspire Medical Systems, Inc.

    11.7.1 Overview

    11.7.2 Product Overview

    11.7.3 Financials

    11.7.4 Key Developments

    11.7.5 SWOT Analysis

    11.8 Others

    Chapter 12 MRFR Conclusion

    12.1 Key Findings

    12.1.1 From CEO’s View Point

    12.1.2 Unmet Needs Of The Market

    12.2 Key Companies To Watch

    12.3 Prediction Of Healthcare Industry

    Chapter 13 Appendix


    LIST OF TABLES

    Table 1 Meralgia ParestheticaIndustry Synopsis, 2020 – 2027

    Table 2 Global Meralgia Paresthetica Market Estimates And Forecast, 2020 – 2027, (USD Million)

    Table 3 Global Meralgia Paresthetica Market By Region, 2020 – 2027, (USD Million)

    Table 4 Global Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 5 Global Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 6 Global Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 7 North America Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 8 North America Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 9 North America Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 10 US Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 11 US Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 12 US Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 13 Canada Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 14 Canada Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 15 Canada Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 16 South America Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 17 South America Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 18 South America Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 19 Europe Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 20 Europe Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 21 Europe Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 22 Western Europe Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 23 Western Europe Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 24 Western Europe Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 25 Eastern Europe Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 26 Eastern Europe Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 27 Eastern Europe Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 28 Asia Pacific Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 29 Asia Pacific Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 30 Asia Pacific Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

    Table 31 Middle East & Africa Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

    Table 32 The Middle East & Africa Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

    Table 33 The Middle East & Africa Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation For Global Meralgia Paresthetica Market

    Figure 3 Segmentation Market Dynamics For Global Meralgia Paresthetica Market

    Figure 4 Global Meralgia Paresthetica Market Share, By Diagnosis 2020

    Figure 5 Global Meralgia Paresthetica Market Share, By Treatment 2020

    Figure 6 Global Meralgia Paresthetica Market Share, By End Users, 2020

    Figure 7 Global Meralgia Paresthetica Market Share, By Region, 2020

    Figure 8 North America Meralgia Paresthetica Market Share, By Country, 2020

    Figure 9 Europe Meralgia Paresthetica Market Share, By Country, 2020

    Figure 10 Asia Pacific Meralgia Paresthetica Market Share, By Country, 2020

    Figure 11 Middle East & Africa Meralgia Paresthetica Market Share, By Country, 2020

    Figure 12 Global Meralgia Paresthetica Market: Company Share Analysis, 2020 (%)

    Figure 13 LivaNova PLC: Key Financials

    Figure 14 LivaNova PLC: Segmental Revenue

    Figure 15 LivaNova PLC: Geographical Revenue

    Figure 16 EnteroMedics Inc: Key Financials

    Figure 17 EnteroMedics Inc: Segmental Revenue

    Figure 18 EnteroMedics Inc: Geographical Revenue

    Figure 19 ElectroCore Medical LLC: Key Financials

    Figure 20 ElectroCore Medical LLC: Segmental Revenue

    Figure 21 ElectroCore Medical LLC: Geographical Revenue

    Figure 22 Boston Scientific Corporation: Key Financials

    Figure 23 Boston Scientific Corporation: Segmental Revenue

    Figure 24 Boston Scientific Corporation: Geographical Revenue

    Figure 25 Cyberonics, Inc.: Key Financials

    Figure 26 Cyberonics, Inc: Segmental Revenue

    Figure 27 Cyberonics, Inc: Geographical Revenue

    Figure 28 NeuroMetrix, Inc..: Key Financials

    Figure 29 NeuroMetrix, Inc.: Segmental Revenue

    Figure 30 NeuroMetrix, Inc..: Geographical Revenue

    Figure 31 Inspire Medical Systems, Inc.: Key Financials

    Figure 32 Inspire Medical Systems, Inc.: Segmental Revenue

    Figure 33 Inspire Medical Systems, Inc.: Geographical Revenue

    Bottom of Form